NCT06262659

Brief Summary

Arteriovenous fistulas (AVF) are considered essential and the primary vascular access for end-stage renal disease patients to receive hemodialysis (HD) treatment. The maturation failure rate of AVFs is approximately 23%. The aim of our study is to compare intraoperative fistula flow and measurements of vascular structures' diameters with postoperative fistula maturation, following the completion of the fistula operation, to reveal the relationship between them. Providing insights into the need for intraoperative intervention and/or postoperative fistula management based on these measurements is intended to contribute to the literature by offering predictions and perspectives.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 5, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 16, 2024

Completed
21 days until next milestone

Study Start

First participant enrolled

March 8, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 10, 2024

Completed
Last Updated

December 5, 2024

Status Verified

December 1, 2024

Enrollment Period

3 months

First QC Date

February 5, 2024

Last Update Submit

December 4, 2024

Conditions

Keywords

arteriovenous fistulafistula flowvascular diameterintraoperative Doppler Ultrasoundarteriovenous fistula maturation

Outcome Measures

Primary Outcomes (1)

  • intraoperative Arteriovenous Fistula Flow Measurement

    AVF flow measurement will be conducted intraoperatively using Doppler ultrasonography (B-Mode and duplex ultrasound on the LOQIC; GE Healthcare Technologies, Milwaukee, Wisconsin, United States). For each patient, AVF flows will be recorded by taking at least 3 measurements of AVF flow, at 2, 5, 10, and 15 cm proximal to the AVF anastomosis, and arithmetic averages will be calculated. AVF flow will be expressed in "ml/min".

    1 hour

Study Arms (1)

group fistula

Preoperative age, gender, weight, height, body mass index, diabetes mellitus, hypertension, asthma, smoking status, postoperative chest pain, intraoperative AVF flow, AVF depth, AVF vascular diameter, and postoperative 6th-week Doppler ultrasonography measurements of AVF flow, AVF depth, and AVF vascular diameter will be recorded for the patients included in the study. Maturation assessment will be made based on these results. AVF flow measurement will be performed intraoperatively and at the 6th week postoperatively using Doppler ultrasonography (B-Mode and duplex ultrasound on the LOQIC; GE Healthcare Technologies, Milwaukee, Wisconsin, United States). For each patient, AVF flows will be recorded by taking at least 3 measurements of AVF flow, depth, and vascular diameters at 2, 5, 10, and 15 cm proximal to the AVF anastomosis, and arithmetic averages will be calculated.

Other: Doppler Ultrasonography Assessment

Interventions

Preoperative data will be collected from the latest available data within the last month. Preoperative Doppler ultrasonography venous mapping for all patients will be performed by experienced Radiology Specialists. AVF flow measurement will be performed intraoperatively and at the 6th week postoperatively using Doppler ultrasonography (B-Mode and duplex ultrasound on the LOQIC; GE Healthcare Technologies, Milwaukee, Wisconsin, United States). For each patient, AVF flows will be recorded by taking at least 3 measurements of AVF flow, depth, and vascular diameters at 2, 5, 10, and 15 cm proximal to the AVF anastomosis, and arithmetic averages will be calculated. AVF flow will be expressed in "ml/min," and the vascular structure diameters and the distance of AVF from the skin will be indicated in "mm." AVF depth will be calculated as the distance from the skin to the anterior wall of the AVF.

group fistula

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients undergoing the first-time autologous arteriovenous fistula creation surgery in end-stage renal failure will be included in the study.

You may qualify if:

  • Patients in need of AVF for hemodialysis due to end-stage renal failure,
  • Patients aged 18 and older but younger than 70,
  • Patients who have not undergone dialysis before,
  • Patients with normal sinus rhythm on EKG,
  • Patients with triphasic flow in upper extremity arterial Doppler ultrasonography,
  • Patients with a minimum vessel diameter of ≥2 mm for arteries and ≥2.5 mm for veins on Doppler ultrasonography.

You may not qualify if:

  • Patients with reduced ejection fraction (EF) (\<50%),
  • Patients with heart valve disease,
  • Patients with coronary artery disease or those who have undergone coronary artery bypass grafting surgery,
  • Patients with a history of fistula creation,
  • Patients undergoing fistula revision,
  • Patients with peripheral vascular disease,
  • Patients with venous embolism/thrombosis or occlusion history in the upper extremity superficial/deep venous system, superior vena cava,
  • Patients with arterial embolism or occlusion in the upper extremity,
  • Patients with burn scars in the upper extremity,
  • Patients with atrophy/paralysis/plegia in the upper extremity,
  • Patients with uncontrolled diabetes,
  • Patients with connective tissue disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kudret Atakan Tekin

Merkez, Çorum, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Arteriovenous Fistula

Condition Hierarchy (Ancestors)

Arteriovenous MalformationsVascular MalformationsCardiovascular AbnormalitiesCardiovascular DiseasesVascular FistulaVascular DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesFistulaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 5, 2024

First Posted

February 16, 2024

Study Start

March 8, 2024

Primary Completion

June 10, 2024

Study Completion

September 10, 2024

Last Updated

December 5, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations